Bayer faces $2.5 billion class-action lawsuit in Germany over Roundup

Investors are demanding nearly €2.2 billion ($2.5 billion) from pharmaceutical firm Bayer AG in a possible German class-action lawsuit over Bayer’s $63 billion acquisition of U.S.-based agrochemical company Monsanto Co. in 2016, Reuters reported. According to the German law firm Tilp, Bayer deceived investors about the risks of pending U.S. consumer lawsuits related to Monsanto’s infamous weedkiller Roundup.